Zurn Elkay Water Solutions Corp
ZWS NYSE General Industrial Machinery & Equipment Financials FY2014βFY2025
What Zurn Elkay Water Solutions Corp does
No business description yet.
- Legal name
- Zurn Elkay Water Solutions Corp
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 9, 2026
- Accession Β· CIK
- 0001628280-26-006372
0001439288
Revenue and margins
Zurn Elkay Water Solutions Corp had $1.7B of revenue in fiscal 2025, up 8.3% on the year before.
Net income and earnings per share
From fiscal 2014 to 2025, diluted EPS grew 4.1% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Zurn Elkay Water Solutions Corp returned $224M to shareholders in fiscal 2025. The diluted share count fell 1.9%.
Balance sheet
Cash, debt and the ratios that show how comfortably Zurn Elkay Water Solutions Corp can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $96.6M | $125M | $137M | $198M | $301M |
| Debt incl. finance leases | $540M | $537M | $517M | $516M | $517M |
| Net debt / EBITDA | 2.9x | 3.2x | 1.7x | 1.2x | 0.7x |
| Debt / equity | 4.3x | 0.3x | 0.3x | 0.3x | 0.3x |
| Interest coverage | 3.1x | 4.0x | 5.0x | 7.4x | 9.8x |
| Current ratio | 2.0x | 2.6x | 3.0x | 2.9x | 3.1x |
| Quick ratio | 1.2x | 1.4x | 1.8x | 1.8x | 2.1x |
| Total assets | $1.1B | $2.9B | $2.7B | $2.6B | $2.7B |
| Total liabilities | $951M | $1.2B | $1.1B | $1.1B | $1.1B |
| Shareholders' equity | $126M | $1.6B | $1.6B | $1.6B | $1.6B |
| Net debt (β = net cash) | $443M | $412M | $380M | $318M | $216M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY14 | FY15 | FY16 | FY17 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 5 / 9 | 7 / 9 | 7 / 9 | β / 3 | 6 / 9 | 5 / 9 | 8 / 9 | 7 / 9 | 8 / 9 |
| Accruals ratio | β4.8% | β4.5% | β3.5% | β4.4% | β6.6% | β4.6% | β1.8% | β5.1% | β5.0% | β5.6% |
| Altman Z'' | 1.75 | 1.96 | 2.23 | 2.15 | 2.62 | β1.51 | 1.36 | 1.72 | 1.93 | 2.24 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY14 | FY15 | FY16 | FY17 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $2.1B | $1.9B | $1.7B | $1.9B | $2.1B | $911M | $1.3B | $1.5B | $1.6B | $1.7B |
| Gross profit | $746M | $665M | $626M | $707M | $785M | $373M | $466M | $648M | $707M | $765M |
| Research and development | $12.8M | $12.4M | $10.4M | $13.3M | $16.3M | β | β | β | β | β |
| Operating income | $204M | $174M | $203M | $266M | $306M | $107M | $107M | $191M | $245M | $279M |
| Interest expense | $87.9M | $91.4M | $88.3M | $75.1M | $69.9M | $34.7M | $26.9M | $38.5M | $33.1M | $28.6M |
| Pretax income | $109M | $86.0M | $82.0M | $56.5M | $239M | $52.4M | $83.8M | $147M | $207M | $256M |
| Income tax | $16.8M | $17.1M | $15.6M | β$19.5M | $53.4M | $2.7M | $26.8M | $42.6M | $48.1M | $63.9M |
| Net income | $83.8M | $67.9M | $74.1M | $75.9M | $34.3M | $121M | $61.7M | $113M | $160M | $198M |
| Net income to common | $83.8M | $67.9M | $66.8M | $52.7M | $11.1M | $121M | β | β | β | β |
| Diluted EPS | $0.80 | $0.66 | $0.64 | $0.62 | $0.28 | $0.97 | $0.40 | $0.64 | $0.92 | $1.15 |
| Diluted shares | 0.10B | 0.10B | 0.10B | 0.12B | 0.12B | 0.13B | 0.15B | 0.18B | 0.17B | 0.17B |
| Cash flow | ||||||||||
| Cash from operations | $246M | $219M | $195M | $229M | $258M | $224M | $97.0M | $254M | $294M | $347M |
| Capital expenditure | $48.8M | $52.1M | $50.8M | $38.0M | $42.5M | β | β | β | β | β |
| Free cash flow | $197M | $167M | $144M | $191M | $216M | β | β | β | β | β |
| Depreciation and amortization | $112M | $115M | $96.1M | $79.7M | $87.9M | $44.1M | $20.5M | $29.2M | $29.2M | $30.0M |
| Stock-based compensation | $6.4M | $7.5M | $13.4M | $20.5M | $22.6M | $51.4M | $25.0M | $40.0M | $37.9M | $40.6M |
| Acquisitions | $138M | β$1.1M | $214M | $174M | $23.4M | $17.1M | $44.8M | $0.0M | $0.0M | β |
| Share buybacks | $0.0M | $40.0M | $0.0M | $0.0M | $0.0M | $0.9M | $24.7M | $125M | $150M | $160M |
| Dividends paid | β | β | β | $0.0M | $0.0M | $36.4M | $32.5M | $50.4M | $56.6M | $63.9M |
| Dividends and buybacks | $0.0M | $40.0M | $0.0M | $0.0M | $0.0M | $37.3M | $57.2M | $176M | $207M | $224M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $370M | $485M | $490M | $193M | $62.3M | $96.6M | $125M | $137M | $198M | $301M |
| Total debt | $1.9B | $1.9B | $1.6B | $1.4B | $1.1B | $540M | $536M | $495M | $496M | $497M |
| Finance lease liabilities | β | β | β | $7.5M | $73.4M | $0.3M | $0.6M | $21.7M | $20.6M | $20.1M |
| Current assets | $1.1B | $1.2B | $1.2B | $998M | $908M | $475M | $758M | $668M | $722M | $812M |
| Current liabilities | $433M | $404M | $400M | $454M | $318M | $240M | $289M | $221M | $248M | $259M |
| Inventory | $368M | $327M | $315M | $304M | $136M | $185M | $367M | $278M | $273M | $274M |
| Property and equipment, net | $418M | $397M | $401M | $397M | $435M | $64.4M | β | β | β | β |
| Goodwill | $1.2B | $1.2B | $1.2B | $1.3B | $245M | $254M | $777M | $796M | $794M | $795M |
| Intangible assets | $588M | $521M | $559M | $531M | $200M | $179M | $1.0B | $952M | $892M | $835M |
| Total assets | $3.4B | $3.4B | $3.5B | $3.4B | $3.4B | $1.1B | $2.9B | $2.7B | $2.6B | $2.7B |
| Total liabilities | $2.9B | $2.8B | $2.5B | $2.2B | $2.0B | $951M | $1.2B | $1.1B | $1.1B | $1.1B |
| Preferred stock | $0.0M | $0.0M | $0.0M | $0.0M | β | β | β | β | β | β |
| Shareholders' equity | $553M | $589M | $1.1B | $1.2B | $1.4B | $126M | $1.6B | $1.6B | $1.6B | $1.6B |
| Margins | ||||||||||
| Gross margin | 36.4% | 34.6% | 36.6% | 38.2% | 38.3% | 41.0% | 36.3% | 42.3% | 45.1% | 45.1% |
| Operating margin | 9.9% | 9.1% | 11.9% | 14.4% | 14.9% | 11.7% | 8.4% | 12.5% | 15.6% | 16.4% |
| EBITDA margin | 15.4% | 15.1% | 17.5% | 18.7% | 19.2% | 16.6% | 10.0% | 14.4% | 17.5% | 18.2% |
| Net margin | 4.1% | 3.5% | 4.3% | 4.1% | 1.7% | 13.3% | 4.8% | 7.4% | 10.2% | 11.7% |
| FCF margin | 9.6% | 8.7% | 8.4% | 10.3% | 10.5% | β | β | β | β | β |
| Returns | ||||||||||
| Return on capital | 8.1% | 6.9% | 7.5% | 11.2% | 9.5% | 17.8% | 3.6% | 6.9% | 10.0% | 11.6% |
| Return on capital employed | 6.8% | 5.9% | 6.5% | 9.0% | 9.9% | 12.8% | 4.2% | 7.8% | 10.2% | 11.5% |
| Return on equity | 15.2% | 11.9% | 8.9% | 6.6% | 2.4% | 15.4% | 7.1% | 7.0% | 10.0% | 12.4% |
| Return on assets | 2.5% | 2.0% | 2.1% | 2.2% | 1.0% | 5.4% | 3.1% | 4.1% | 6.0% | 7.4% |
| Return on tangible equity | β | β | β | β | 1.1% | β | β | β | β | β |
| Growth | ||||||||||
| Revenue growth | β | β6.2% | β11.0% | 8.1% | β | β55.6% | 40.7% | 19.4% | 2.4% | 8.3% |
| Net income growth | β | β19.0% | 9.1% | 2.4% | β | 252.5% | β49.0% | 82.7% | 42.1% | 23.6% |
| EPS growth | β | β17.5% | β3.0% | β3.1% | β | 246.4% | β58.8% | 60.0% | 43.8% | 25.0% |
| FCF growth | β | β15.3% | β13.5% | 32.0% | β | β | β | β | β | β |
| Share count change | β | β1.4% | 1.4% | 16.4% | β | 1.4% | 23.0% | 15.2% | β1.5% | β1.9% |
| Financial health | ||||||||||
| Net debt / EBITDA | 5.0x | 5.0x | 3.8x | 3.4x | 2.9x | 2.9x | 3.2x | 1.7x | 1.2x | 0.7x |
| Debt / equity | 3.5x | 3.3x | 1.5x | 1.1x | 0.8x | 4.3x | 0.3x | 0.3x | 0.3x | 0.3x |
| Interest coverage | 2.3x | 1.9x | 2.3x | 3.5x | 4.4x | 3.1x | 4.0x | 5.0x | 7.4x | 9.8x |
| Current ratio | 2.6x | 2.9x | 2.9x | 2.2x | 2.9x | 2.0x | 2.6x | 3.0x | 2.9x | 3.1x |
| Quick ratio | 1.8x | 2.1x | 2.2x | 1.5x | 2.4x | 1.2x | 1.4x | 1.8x | 1.8x | 2.1x |
| Capital allocation | ||||||||||
| Capex / revenue | 2.4% | 2.7% | 3.0% | 2.1% | 2.1% | β | β | β | β | β |
| Stock comp / revenue | 0.3% | 0.4% | 0.8% | 1.1% | 1.1% | 5.6% | 2.0% | 2.6% | 2.4% | 2.4% |
| Payouts / FCF | 0.0% | 24.0% | 0.0% | 0.0% | 0.0% | β | β | β | β | β |
| Quality scores | ||||||||||
| Piotroski F-score | β | 5.0 | 7.0 | 7.0 | β | 6.0 | 5.0 | 8.0 | 7.0 | 8.0 |
| Altman Z'' | 1.8 | 2.0 | 2.2 | 2.1 | 2.6 | β1.5 | 1.4 | 1.7 | 1.9 | 2.2 |
| Accruals ratio | β4.8% | β4.5% | β3.5% | β4.4% | β6.6% | β4.6% | β1.8% | β5.1% | β5.0% | β5.6% |
Source: SEC EDGAR XBRL filings (CIK 0001439288). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.